博士伦:市场正在为其资产负债表定价,而非其眼保健业务引擎
· seekingalpha.com
博士伦(BLCO)扭亏为盈:2026年第二季度营收同比增长9%,利润率扩大,现金流强劲。了解去杠杆化和业务组合转变如何可能带来估值重估。
I am optimistic about the future performance of Bausch + Lomb ( BLCO ), based primarily on the expectation that investors will continue to view the company as a...